Appeal No. 2001-0964
Application No. 09/069,442
electroplating bath which include the ingredients required by the
here rejected claims. Thus, it would have been obvious for one
with ordinary skill in the art to select from Korbelak’s
ingredient-lists the specific ingredients under consideration
based upon patentee’s teaching that such ingredients are
effective in his desired electroplating bath formulations.
Merck & Co. v. Biocraft Labs., Inc., 874 F.2d at 807-08,
10 USPQ2d at 1846.
These specific ingredients include: a cyanide-containing
gold compound such as potassium gold cyanide as Korbelak’s first
component (e.g., see lines 50-54 in column 1); an iron compound
such as iron sulfate as patentee’s fifth component (e.g., see
lines 42-55 in column 2); a zirconium compound such as zirconium
sulfate as his second component (e.g., see line 57 in column 1,
lines 3-14 in column 2 and Table II in column 6); a citrate
compound such as a metal citrate as patentee’s fourth component
(e.g., see lines 29-41 in column 2) or as patentee’s fifth
component (again see lines 42-55 in column 2); and a weak acid
such as citric, malic, lactic, glycolic or tartaric acid as
patentee’s third component (e.g., see lines 19-28 in column 2).
13
Page: Previous 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next
Last modified: November 3, 2007